P. Becker

发表

The Appropriate Use of Opioids in the Treatment of Refractory Restless Legs Syndrome

A. Walters, W. Ondo, M. Silber, 2018, Mayo Clinic proceedings.

Put Your Patients to Sleep: Useful Nondrug Strategies for Chronic Insomnia; Sleep Diaries and Dispelling Dysfunctional Beliefs May Be as Effective as Hypnotics

P. Becker, 2008 .

Nightmare distress and subsyndromal psychotic experiences.

P. Becker, 2020, Sleep medicine.

Overview of sleep management during COVID-19

P. Becker, 2021, Sleep Medicine.

Chapter 32 – Opioid Agents in the Treatment of Restless Legs Syndrome

P. Becker, 2009 .

Novel therapeutic usage of low-dose doxepin hydrochloride

P. Becker, H. Singh, 2007, Expert opinion on investigational drugs.

Treatment of sleep dysfunction and psychiatric disorders

P. Becker, Muhammad Sattar, 2006, Current treatment options in neurology.

A randomized, double-blind, placebo-controlled, crossover study of XP13512/GSK1838262 in the treatment of patients with primary restless legs syndrome.

A. Walters, C. Kushida, T. Roth, 2009, Sleep.

Dopaminergic agents in restless legs syndrome and periodic limb movements of sleep: response and complications of extended treatment in 49 cases.

P. Becker, A. Jamieson, W. D. Brown, 1993, Sleep.

A multicenter evaluation of oral pressure therapy for the treatment of obstructive sleep apnea.

A. Malhotra, I. Colrain, R. Bogan, 2013, Sleep medicine.

Title A multicenter evaluation of oral pressure therapy for the treatment of obstructive sleep apnea

A. Malhotra, I. Colrain, R. Bogan, 2013 .

The biopsychosocial effects of restless legs syndrome (RLS)

P. Becker, 2006, Neuropsychiatric disease and treatment.

Management of the 10 most common sleep disorders.

P. Becker, A. Jamieson, 1992, American family physician.

Bleed less than 3: RLS and blood donation.

P. Becker, 2009, Sleep medicine.

Wake up to insomnia diagnosis: Asking the right questions of who, where, when, and what.

P. Becker, 2009, Sleep medicine.

Mood, behavior, and sleepiness of sleep-related movement disorders

P. Becker, 2021, Reference Module in Neuroscience and Biobehavioral Psychology.

Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy

N. Feldman, R. Hughes, J. Schwartz, 2003, Psychopharmacology.

Insomnia: prevalence, impact, pathogenesis, differential diagnosis, and evaluation.

P. Becker, Philip M Becker, 2006, The Psychiatric clinics of North America.

Rotigotine improves restless legs syndrome: A 6‐month randomized, double‐blind, placebo‐controlled trial in the United States

A. Walters, W. Hening, W. Ondo, 2010, Movement disorders : official journal of the Movement Disorder Society.

Non-Benzodiazepine Receptor Agonists for Insomnia.

P. Becker, Manya Somiah, 2015, Sleep medicine clinics.

Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS

C. Kushida, P. Becker, A. Ellenbogen, 2009, Neurology.

Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy

Christian Guilleminault, David M. Rapoport, Russell Rosenberg, 2000, Neurology.

Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome.

W. Ondo, M. Silber, D. Garcia-Borreguero, 2013, Mayo Clinic proceedings.

Treatment of sleep dysfunction and psychiatric disorders

P. Becker, 2009, Current treatment options in neurology.

Mood disorders in restless legs syndrome (Willis-Ekbom disease).

P. Becker, D. Sharon, 2014, The Journal of clinical psychiatry.

Treatment of sleep-related movement disorders

P. Becker, 2021, Reference Module in Neuroscience and Biobehavioral Psychology.

Diagnosis of Restless Leg Syndrome (Willis-Ekbom Disease).

P. Becker, Philip M Becker, 2015, Sleep medicine clinics.

Diagnosis, comorbidities, and management of restless legs syndrome

M. Novak, P. Becker, 2014, Current medical research and opinion.

Review article Diagnosis, comorbidities, and management of restless legs syndrome

M. Novak, P. Becker, 2014 .

Family history study of the restless legs syndrome.

R. Allen, C. Earley, P. Becker, 2002, Sleep medicine.

Encouraging initial response of restless legs syndrome to pramipexole

W. Ondo, P. Becker, D. Sharon, 1998, Neurology.

A 52-Week Study of Gabapentin Enacarbil in Restless Legs Syndrome

J. Tolson, P. Becker, S. Thein, 2011, Clinical neuropharmacology.

Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome.

C. Kushida, R. Allen, R. Bogan, 2004, Sleep.

Hypnosis in the Management of Sleep Disorders.

P. Becker, 2015, Sleep medicine clinics.

Chronic insomnia: outcome of hypnotherapeutic intervention in six cases.

P. Becker, 1993, The American journal of clinical hypnosis.

Insomnia. Use of a 'decision tree' to assess and treat.

P. Becker, A. Jamieson, W. D. Brown, 1993, Postgraduate medicine.

Pharmacologic and nonpharmacologic treatments of insomnia.

P. Becker, 2005, Neurologic clinics.

Efficacy and safety of pramipexole in restless legs syndrome

C. Kushida, K. Sethi, J. Koester, 2006, Neurology.

Validation of the self-administered version of the international Restless Legs Syndrome study group severity rating scale - The sIRLS.

A. Walters, P. Martínez-Martín, B. Högl, 2019, Sleep medicine.

Pregabalin versus pramipexole: effects on sleep disturbance in restless legs syndrome.

R. Allen, D. Garcia-Borreguero, S. Dubrava, 2014, Sleep.

Common sleep disorders in the elderly: diagnosis and treatment.

P. Becker, A. Jamieson, 1992, Geriatrics.

Gabapentin enacarbil in subjects with moderate to severe primary restless legs syndrome with and without severe sleep disturbance: an integrated analysis of subjective and novel sleep endpoints from two studies

W. Ondo, C. Kushida, R. Bogan, 2013 .

Gabapentin Enacarbil in Restless Legs Syndrome: A Phase 2b, 2-Week, Randomized, Double-Blind, Placebo-Controlled Trial

A. Walters, W. Ondo, C. Kushida, 2009, Clinical neuropharmacology.

Trazodone as a hypnotic in major depression.

P. Becker, 2004, Sleep medicine.

Identifying clinically important difference on the Epworth Sleepiness Scale: results from a narcolepsy clinical trial of JZP-110.

P. Becker, H. Emsellem, J. Black, 2017, Sleep medicine.